Industry Executive Insights Summary: 2025 Finance & Budget Priorities - Health System Leaders Share What’s Ahead
Industry Executive Insights Summary: Health System Finance Priorities Shaping Therapy Access and Adoption
Key Insights from the 2025 Health System Finance Executive Survey Results
THMA conducted a double-blind survey of 40 CFOs and VPFs from large U.S. health systems (>$750M annual revenue) to uncover budget and investment priorities shaping the year ahead, and we’re sharing a limited-time summary with pharmaceutical teams selling into large health systems.
Download our Industry Executive Insights Summary to:
Gain perspective on investment priorities, evolving care models, and the financial conditions that determine whether therapies can be supported at scale
Understand how health systems are managing trade-offs across access, revenue integrity, cost containment, and workforce constraints that influence adoption decisions
Examine the federal policy changes with the greatest financial implications, including Medicaid reform, 340B drug pricing, and site-neutral payment policies
We will contact you with more information.

Trusted By






